Tenaya Therapeutics Is A Clinical Stage Biotechnology Company Based In South San Franciscocaliforniathe Company Is Dedicated To Developing Therapies That Target The Root Causes Of Heart Diseaseit Employs An Integrated Approach Using Three Proprietary Platformscellular Regenerationgene Therapyand Precision Medicinetenaya Collaborates With Institutions Like Gladstone Institutes And The University Of Texas Southwestern Medical Center To Advance Its Research The Company Focuses On Addressing Both Rare Genetic Cardiovascular Disorders And Common Heart Conditions Through Disease Modifying Therapiesits Pipeline Includes Gene Therapies Such As Tn 201 For Hypertrophic Cardiomyopathy And Tn 401 For Arrhythmogenic Right Ventricular Cardiomyopathyas Well As Small Molecule Therapies Like Tn 301 For Heart Failuretenaya S Mission Is To Discover And Deliver Potentially Curative Therapies That Address Underlying Disease Driversaiming To Transform Cardiovascular Treatment With Durableone Time Solutions
